President Trump reverses Biden's order to cap out-of-pocket costs for prescription drugs, potentially increasing costs for Medicare and Medicaid recipients.
Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...